EconPapers    
Economics at your fingertips  
 

High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids’ Inpatient Database (KID)

Jessica Cardenas, Melissa Menier, Marjet D. Heitzer and Douglas M. Sproule ()
Additional contact information
Jessica Cardenas: AveXis, Inc
Melissa Menier: AveXis, Inc
Marjet D. Heitzer: AveXis, Inc
Douglas M. Sproule: AveXis, Inc

PharmacoEconomics - Open, 2019, vol. 3, issue 2, No 9, 205-213

Abstract: Abstract Background Patients with spinal muscular atrophy (SMA) have high healthcare resource use (HRU) due to respiratory and nutritional complications resulting from progressive muscle atrophy. While previous studies estimate the direct costs to be US$113,000 to US$121,682 per year in the US, they potentially understate costs for type 1 SMA (SMA1). This study analyzed HRU in hospitalizations with a diagnosis of SMA1 and compared it with hospitalizations with complex chronic conditions (CCC) other than SMA1 or those with no CCC. Methods This retrospective analysis of a defined subset of the 2012 Kids’ Inpatient Database (KID) compared a nationally estimated number of hospitalizations of children (aged

Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s41669-018-0093-0 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:3:y:2019:i:2:d:10.1007_s41669-018-0093-0

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-018-0093-0

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-20
Handle: RePEc:spr:pharmo:v:3:y:2019:i:2:d:10.1007_s41669-018-0093-0